Kidney stone disease has a multifactorial etiology involving the interaction of genetic and environmental factors. There is an increased risk of stone formation in the relatives of idiopathic stone patients, which can be explained up to 60% by genetic factors. This study was conducted to explore the association of vitamin D receptor (VDR) gene polymorphisms with the risk of urolithiasis (UL) in Turkish children.
Urolithiasis (UL) is a multifactorial disease, the onset and severity of which is influenced by both genetic and environmental factors. It is seen that 50-70% stone disease patients have a first degree relative with UL and a family history was reported to increase the disease risk, 2.57 times in males. 1, 2 Additionally, studies of kidney stone-forming twins demonstrated a higher concardance for kidney stones in monozygotic than in dizygotic twins. 3 It is still not clear whether the increased risk is attributable to genetic factors, environmental factors or some combination. The genes responsible for heritability of UL are still not determined; however, several genetic loci that appear to have a minor contribution to UL have been identified like vitamin D receptor (VDR), vascular endothelial growth factor, E-cadherin, p21, calcium-sensing receptor, calcitonin receptor and osteopontin 4 . Among them, the VDR gene is the most widely studied.
The VDR gene is located on chromosome 12 and encodes VDR. The effect of vitamin D which is a key player in calcium metabolism is mediated by the interaction between its active metabolite, calcitriol, and its cellular receptor, VDR, on target cells. 5 In view of their potential influence on the hormonal signal, VDR gene polymorphisms have been studied in disorders of calcium metabolism and in urinary calcium stone disease. [6] [7] [8] [9] [10] Four single nucleotide polymorphisms (SNPs) of the VDR gene, ApaI, BsmI, TagI, and FokI, which were hypothesized to influence the expression and/or function of the VDR protein have been widely studied to investigate the associations between these polymorphisms and the risk of UL, however, the results were inconclusive.
To evaluate a more precise estimation of the relationship, to date, four meta-analyses were performed [11] [12] [13] [14] (Table I) . Lin et al. 11 found a significant associations of FokI and TagI polymorphisms with UL risk. Zhang et al. 12 found associations between the ApaI and TagI SNPs and UL. Liu et al. 13 demonstrated that only TagI polymorphisms was associated with UL risk, whereas ApaI, BsmI, and FokI polymorphisms were not. The most recent study by Zhou et all. 14 
Material and Methods
Patient selection and urinary metabolic examinations. The present study is a casecontrol study. Fifty-two children with UL and fifty-one age and sex matched children were enrolled in this study. A diagnosis of UL was based on imaging (ultrasonography (US) or computed tomography). All of the cases were re-evaluated in our centre with serial US examinations 1-3 months later to confirm the diagnosis, exclude artefacts and follow UL status. A metabolic evaluation was performed including serum electrolytes and tests for metabolic risk factors, including hypercalciuria, hypocitraturia, cystinuria, hyperoxaluria, hyperuricosuria and hyperphosphaturia were carried out. Urinary solute abnormalities was detected by abnormal values in two consecutive 24-hour urine collections or spot urine samples. Hypercalciuria was diagnosed if the amounts of calcium in the urine exceeded 4 mg/kg per 24 h (0.1 mmol/kg/ 24 h) and/or the urinary calcium/creatinine ratio exceeded 0.8 mg/mg for 0-12 months, 0.53 mg/mg for 1-3 years, 0.4 mg/mg for 3-5 years, 0.3 mg/mg for 5-7 years and 0.21 mg/mg for children older than 7 years of age. 15, 16 The normal value for urine citrate was accepted as >1.6 mmol/1.73m 2 /24-hour and/or a urine citrate/creatinine ratio >0.1 mol/mol creatinine. 17 All control subjects were screened for UL by urinary US. Those who had UL were excluded. The exclusion criteria for patients and controls were the presence of recurrent urinary tract infection, renal failure, other metabolic diseases, hypercalcemia, hyperphosphatemia, primary and secondary hyperparathyroidism, hypervitaminosis D, chronic diarrhea, cancer, and osteoporosis. This study was approved by the local ethics committee and informed consent was obtained in all cases.
DNA extraction. Genomic DNA isolations were performed from 200 μl peripheral blood (EDTA-anticoagulated) leukocytes by using QIAamp DNA Blood Mini Kit (Qiagen Inc.) according to the manufacturer's protocol and stored at -20 0 C until the PCR (polymerase chain reaction) step.
Determination of Genotypes. Screening of polymorphisms was carried out by using SNaPshot® multiplex system (Applied Biosystems Inc.). For this purpose, 3 primers were designed for each amplicons; 2 for PCR and 1 for SNaPshot® reaction for polymorphisms Cdx2, FokI, BsmI, ApaI and Taq . Four PCRs were set for each sample (ApaI and TaqI were amplified with same reaction). Briefly, 2μl of genomic DNA and 20.2 μl of water were amplified in an automated thermal cycler. PCRs were checked by using 2% agarose gel electrophoresis. All 4 reactions for one patient's sample were mixed and purified by using NucleoFast® 96 PCR kit (MACHEREY-NAGEL GmbH). Purified PCRs were used in SNaPshot® assay which carried out according to the manufacturer's recommendations. Capillary electrophoresis of the SNaPshot® reactions were carried out by using ABI 3130 capillary electrophoresis instrument (Applied Biosystems Inc. (Table II) . Urinary metabolic examination revealed that most common pathologic findings were hypocitraturia and hypercalciuria. Only 30% of the cases were normal for all parameters (Table II) . Our data provide no statistically significant evidence for an association between UL and VDR ApaI, BsmI, TagI, Cdx2, and FokI genotype and allele frequencies (Table III, Table IV ). On the other hand, although not statistically significant we found higher genotypic (tt genotype: 44% and 35% for patients and controls respectively, p:0.2) and allelic frequencies (t allele: 68% and 59% for patients and controls respectively, p:0.15) for TaqI in children with UL compared to controls (Table III, Table IV Table I) , suggesting that ethnic differences may play a role in UL susceptibility. [11] [12] [13] [14] It is possible that different UL risks in Asians and Caucasions were due to exposure to various environmental factors in addition to genetic susceptibility.
Turkey which is a country that constitutes a bridge between Europe and Asia has experienced major population movements and one of the significant countries in the world from the genetic diversity (variability) point of view. In a recent study by Hodoğlugil and Mahley 20 , population structure and genetic relatedness of samples from three regions of Turkey, using over 500,000 SNP genotypes, were compared together with Human Genome Diversity Panel data. Principal component analysis, in this study, showed a significant overlap between Turks and Middle Easterners and a relationship with Europeans and South and Central Asians; however, the authors concluded that Turkish genetic structure is unique. As previously mentioned the genetic effect may be different in different populations. Therefore, in our study, we examined VDR gene polymorphisms, ApaI, BsmI, TagI, Cdx2, FokI and their relationship to UL, hypercalciuria and hypocitraturia in a Turkish population having uinique genetic structure and high genetic variability. In addition, to the best of our knowladge, present study is the first study examining the role of Cdx2 polymorphism of the VDR gene in the etiology of UL.
In our study, we did not observe significant evidence for an association between UL and VDR ApaI, BsmI, TagI, Cdx2, and FokI genotype and allele frequencies. There are few studies on the correlation of VDR polymorphism with UL in Turkish children. 6 Gunes et al. 6 demonstrated that the VDR ApaI, BsmI and TagI polymorphisms do not confer a significant risk for UL. Our data is consistent with the findings of Gunes et al. 6 . Although not statistically significant, we found higher genotypic and allelic frequencies for TaqI in children with UL (Table III, Table IV ). Similarly largest 3 of 4 meta-analyses showed an increased risk associated with the TagI tt + TT polymorphism in Asians (Table I) . Findings in meta-analyses and our study indicates that the TagI tt genotype has a close relationship to UL risk especially The present study has some limitations. First, the sample size was relatively small along with the small number of patients with hypercalciuria and hypocitraturia to draw any conclusion. This study was also a single center based study which could be unrepresantative 
